Most scientific work isn’t reproducible. Andy Tay explains why that’s a problem.
The call for reproducibility has never been stronger in the history of science. Since two major pharmaceutical companies, Amgen and Bayer, reported in 2011/12 that their scientists were unable to replicate 80-90% of the findings in landmark papers, scientific news outlets have caught up on the issue. Their reports have catalyzed conversations among stakeholders (policy makers, funding agencies and scientists) to improve reproducibility in science.
There are a lot of reasons why reproducibility is so important, and why Amgen and Bayer’s results caused such controversy. I’ll start at the individual level. Continue reading









